주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
상단영역
UPDATE : 2024-03-29 09:10 (Fri)
Home
Log in
Join
전체메뉴
기사검색
검색
본문영역
Pharma
목록
(
총 :
2,298 )
기사목록 보기 형태
제목형
요약형
포토형
Hanmi Science to merge healthcare subsidiary
Lee Han-soo
2022.08.24 12:00
PharmGen expects larger sales by proving bioequivalence for 29 generic products
Marianne Chang
2022.08.23 18:00
Daewoong to begin phase 3 diabetes trial in China in September
Kim Chan-hyuk
2022.08.23 12:03
April Bio signs license and joint R&D contract with Yuhan
Lee Han-soo
2022.08.23 11:54
Daewoong Pharm's Fexuclue secures additional gastritis indication
Marianne Chang
2022.08.22 15:12
Ildong needs Japan’s nod to win Covid pill permit in Korea
Kim Chan-hyuk
2022.08.22 14:21
‘If I could use Enhertu, I would sell my house,’ says a breast cancer patient
Kim Yun-mi
2022.08.22 12:09
HLB to release phase 3 results of cancer drug candidate at ESMO 2022
Marianne Chang
2022.08.19 17:23
Helixmith discloses IDMC advice on Engensis phase 3-2 clinical trials
Marianne Chang
2022.08.18 16:56
GSK Korea to trim payroll – again
Lee Han-soo
2022.08.18 16:56
Gilead retrieves Trodelvy sales right in Korea
Kim Yun-mi
2022.08.17 15:57
Genexine combines 2 anticancer drug candidates with BMS’ Opdivo for triple combo clinical trials
Marianne Chang
2022.08.17 15:55
처음
이전
이전
이전
111
112
113
114
115
116
117
118
119
120
다음
다음
다음
끝
위로
전체메뉴
All
Hospital
Pharma
Bio
All
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
All
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
ASCO 2020 Highlights
Special Series in Celebration of KBR’s 4th Anniversary
KBR Covering RSNA 2021
Special Series in Celebration of KBR’s 5th Anniversary
Special Report on EULAR 2022
[Top K-Pharma Analysis]
BIO 2023
Opinion
All
Reporter’s Notebook
Journalist’s Column
Congratulatory Remarks
Sponsored
전체메뉴닫기